Published on

Medicine – Dermatological Complications of HIV Infection

Dermatological complications are extremely common in patients with human immunodeficiency virus (HIV) infection, affecting approximately 75% or more of patients in many reported clinical populations. The prevalence varies with immune status, antiretroviral therapy (ART) access and the population studied.

Skin and mucosal manifestations may result from opportunistic infections, inflammatory disorders, malignancies or adverse drug reactions.

Important Clinical Principle

As HIV progresses and CD4+ T-cell counts decline, certain skin infections become more frequent, extensive, persistent, recurrent or resistant to treatment.

1. Seborrhoeic Dermatitis

Seborrhoeic dermatitis is a chronic, relapsing inflammatory skin disorder affecting areas rich in sebaceous glands.

It is particularly common in people living with HIV and may be more severe than in immunocompetent individuals.

Clinical Appearance

Clinical appearance of seborrhoeic dermatitis
Seborrhoeic dermatitis – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Erythematous patches or plaques with greasy, yellowish-white scales.
  • Commonly affects the scalp, eyebrows, nasolabial folds, ears and central chest.
  • May cause itching and irritation.
  • Advanced HIV may be associated with extensive or treatment-resistant disease.

Pathogenesis

Seborrhoeic dermatitis is associated with inflammatory responses to Malassezia yeasts, altered skin barrier function and host immune factors.

Treatment

  • Topical antifungals such as ketoconazole.
  • Short courses of low-potency topical corticosteroids for facial inflammation.
  • Topical calcineurin inhibitors in selected cases.
  • Effective ART may improve disease severity.

2. Candidiasis

Candidiasis is a fungal infection caused most commonly by Candida albicans.

Oral and oesophageal candidiasis are important manifestations of impaired cell-mediated immunity in HIV infection.

Clinical Appearance

Oral candidiasis with white mucosal plaques
Oral candidiasis – clinical image.
Browse source images on Wikimedia Commons

Clinical Types

Type Clinical Features
Pseudomembranous oral candidiasis Creamy white plaques that can usually be scraped off, leaving an erythematous surface
Erythematous candidiasis Red, painful or burning oral mucosa
Angular cheilitis Fissuring and inflammation at the corners of the mouth
Oesophageal candidiasis Dysphagia, odynophagia and possible retrosternal discomfort

Clinical Significance

Oral candidiasis becomes more common as immunosuppression progresses, particularly when CD4 counts decline below approximately 200 cells/µL.

Important Examination Point: Oesophageal candidiasis is an AIDS-defining illness in a person with HIV, irrespective of CD4 count.

Treatment

  • Oropharyngeal candidiasis: topical therapy in selected mild cases or oral fluconazole.
  • Oesophageal candidiasis: systemic antifungal therapy, usually fluconazole.
  • ART is important for immune restoration.

3. Herpes Simplex Virus (HSV) Infection

HSV-1 and HSV-2 cause mucocutaneous infections that may become more frequent, severe or prolonged in patients with advanced HIV.

Clinical Appearance

Herpes simplex infection with grouped vesicles
Herpes simplex infection – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Painful grouped vesicles on an erythematous base.
  • Vesicles rupture, producing erosions or ulcers.
  • Oral, perioral, genital or perianal involvement.
  • Advanced immunosuppression may cause large, deep, atypical or slow-healing lesions.

Clinical Significance

AIDS-Defining Manifestations: Chronic HSV ulcers lasting more than one month, or HSV bronchitis, pneumonitis or oesophagitis with onset after the neonatal period.

Treatment

  • Acyclovir.
  • Valacyclovir.
  • Famciclovir.
  • Intravenous acyclovir for severe or disseminated infection.
  • Resistant HSV may require specialist treatment, such as foscarnet.

4. Varicella-Zoster Virus (VZV) Infection

VZV causes primary varicella (chickenpox) and reactivation disease known as herpes zoster (shingles).

Patients with HIV have an increased risk of herpes zoster, including recurrent and complicated disease.

Clinical Appearance

Herpes zoster with dermatomal vesicular eruption
Herpes zoster – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Painful vesicular eruption.
  • Usually follows a unilateral dermatomal distribution.
  • May be preceded by burning, tingling or neuropathic pain.
  • May involve multiple dermatomes or disseminate in immunocompromised patients.

Complications

  • Postherpetic neuralgia.
  • Herpes zoster ophthalmicus.
  • Secondary bacterial infection.
  • Disseminated cutaneous or visceral infection.

Treatment

  • Oral valacyclovir, famciclovir or acyclovir for uncomplicated localised disease.
  • Intravenous acyclovir for severe or disseminated infection.
  • ART and appropriate vaccination help reduce disease burden.

5. Human Papillomavirus (HPV) Infection

HPV infects squamous epithelial cells and produces cutaneous or anogenital lesions.

In patients with HIV, HPV infection may be persistent, extensive, recurrent or difficult to treat.

Clinical Appearance

Common wart caused by human papillomavirus
Common cutaneous wart – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Common cutaneous warts.
  • Plantar warts.
  • Flat warts.
  • Anogenital warts (condylomata acuminata).
  • Cervical, anal and other HPV-associated intraepithelial lesions.

Important HPV Types

HPV Type Clinical Association
6 and 11 Most anogenital warts; low oncogenic risk
16 and 18 High-risk types associated with cervical, anal and other cancers
1, 2 and 4 Commonly associated with cutaneous warts

Clinical Significance

Persistent infection with high-risk HPV types increases the risk of HPV-associated malignancies.

People living with HIV have increased risks of cervical and anal cancer, among other HPV-related cancers.

Treatment and Prevention

  • Cryotherapy.
  • Site-appropriate topical therapies such as imiquimod.
  • Surgical or ablative treatment when indicated.
  • HPV vaccination according to local recommendations.
  • Appropriate cervical and anal cancer screening.

6. Molluscum Contagiosum

Molluscum contagiosum is caused by a poxvirus, the molluscum contagiosum virus.

It produces characteristic smooth, dome-shaped papules with central umbilication.

Clinical Appearance

Molluscum contagiosum showing centrally umbilicated papules
Molluscum contagiosum – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Small, smooth, pearly or skin-coloured papules.
  • Characteristic central depression or umbilication.
  • Usually painless.
  • May involve the face, trunk, extremities or genital region.

Features in Advanced HIV

  • Numerous lesions.
  • Giant or confluent lesions.
  • Extensive facial involvement.
  • Atypical appearance.
  • Persistent or recurrent infection.

Treatment

Effective ART and immune restoration are central to managing extensive HIV-associated molluscum contagiosum.

Selected lesions may be treated with curettage or cryotherapy, although treatment should be individualised because destructive procedures may cause scarring.

7. Comparison of Dermatological Complications

Condition Cause Characteristic Appearance
Seborrhoeic dermatitis Inflammatory disorder associated with Malassezia Greasy yellowish scales on erythematous skin
Candidiasis Candida species White oral plaques or erythematous mucosa
HSV HSV-1 or HSV-2 Painful grouped vesicles or ulcers
Herpes zoster VZV reactivation Painful dermatomal vesicular eruption
HPV Human papillomavirus Verrucous papules or anogenital warts
Molluscum contagiosum Poxvirus Pearly, centrally umbilicated papules

8. HIV Immunosuppression and Skin Disease

Progressive CD4+ T-cell depletion impairs cell-mediated immunity and increases susceptibility to certain dermatological infections.

Flowchart: Development of Dermatological Complications

HIV Infection CD4+ T-Cell Depletion Progressive immunosuppression Impaired Cell-Mediated Immunity Increased Susceptibility to Skin and Mucosal Infections Extensive, Recurrent or Persistent Lesions ART and Immune Restoration

Effective ART often reduces the frequency and severity of dermatological complications by improving immune function.

Important Clarification: Not all dermatological complications are restricted to advanced HIV. Seborrhoeic dermatitis and herpes zoster may occur at relatively preserved CD4 counts.

9. Other Dermatological Manifestations of HIV

  • Kaposi sarcoma: HHV-8-associated vascular tumour producing violaceous patches, plaques or nodules.
  • Bacillary angiomatosis: Bartonella-associated vascular lesions.
  • Oral hairy leukoplakia: Epstein–Barr virus-associated corrugated white plaques, typically on the lateral tongue.
  • Eosinophilic folliculitis: Pruritic follicular papules, particularly in advanced HIV.
  • Pruritic papular eruption: Intensely itchy papules, often affecting the extremities.
  • Dermatophyte infections: May become extensive, atypical or resistant to treatment.
  • Drug eruptions: May occur with antiretrovirals, antibiotics and other medications.

10. High-Yield Examination Summary

Seborrhoeic Dermatitis

  • Greasy scales on scalp and face.
  • Associated with Malassezia.

Candidiasis

  • Oral white plaques.
  • Oesophageal candidiasis is AIDS-defining.

Herpes Simplex Virus

  • Painful grouped vesicles or ulcers.
  • Chronic ulcers lasting more than one month are AIDS-defining.

Varicella-Zoster Virus

  • Painful dermatomal vesicular rash.
  • May become disseminated in advanced immunosuppression.

Human Papillomavirus

  • Persistent or extensive warts.
  • High-risk types increase the risk of HPV-associated cancers.

Molluscum Contagiosum

  • Pearly, centrally umbilicated papules.
  • Extensive or giant lesions suggest significant immunosuppression.
Most Important Examination Point

Dermatological manifestations are very common in HIV infection. Important examples include seborrhoeic dermatitis, candidiasis, HSV, VZV, HPV and molluscum contagiosum.

With increasing immunosuppression, infections may become unusually severe, extensive, persistent or recurrent. Effective ART is central to prevention and management.

Medicine – HIV Infection Revision Notes

Medicine – Dermatological Complications of HIV Infection

Dermatological complications are extremely common in patients with human immunodeficiency virus (HIV) infection, affecting approximately 75% or more of patients in many reported clinical populations. The prevalence varies with immune status, antiretroviral therapy (ART) access and the population studied.

Skin and mucosal manifestations may result from opportunistic infections, inflammatory disorders, malignancies or adverse drug reactions.

Important Clinical Principle

As HIV progresses and CD4+ T-cell counts decline, certain skin infections become more frequent, extensive, persistent, recurrent or resistant to treatment.

1. Seborrhoeic Dermatitis

Seborrhoeic dermatitis is a chronic, relapsing inflammatory skin disorder affecting areas rich in sebaceous glands.

It is particularly common in people living with HIV and may be more severe than in immunocompetent individuals.

Clinical Appearance

Clinical appearance of seborrhoeic dermatitis
Seborrhoeic dermatitis – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Erythematous patches or plaques with greasy, yellowish-white scales.
  • Commonly affects the scalp, eyebrows, nasolabial folds, ears and central chest.
  • May cause itching and irritation.
  • Advanced HIV may be associated with extensive or treatment-resistant disease.

Pathogenesis

Seborrhoeic dermatitis is associated with inflammatory responses to Malassezia yeasts, altered skin barrier function and host immune factors.

Treatment

  • Topical antifungals such as ketoconazole.
  • Short courses of low-potency topical corticosteroids for facial inflammation.
  • Topical calcineurin inhibitors in selected cases.
  • Effective ART may improve disease severity.

2. Candidiasis

Candidiasis is a fungal infection caused most commonly by Candida albicans.

Oral and oesophageal candidiasis are important manifestations of impaired cell-mediated immunity in HIV infection.

Clinical Appearance

Oral candidiasis with white mucosal plaques
Oral candidiasis – clinical image.
Browse source images on Wikimedia Commons

Clinical Types

Type Clinical Features
Pseudomembranous oral candidiasis Creamy white plaques that can usually be scraped off, leaving an erythematous surface
Erythematous candidiasis Red, painful or burning oral mucosa
Angular cheilitis Fissuring and inflammation at the corners of the mouth
Oesophageal candidiasis Dysphagia, odynophagia and possible retrosternal discomfort

Clinical Significance

Oral candidiasis becomes more common as immunosuppression progresses, particularly when CD4 counts decline below approximately 200 cells/µL.

Important Examination Point: Oesophageal candidiasis is an AIDS-defining illness in a person with HIV, irrespective of CD4 count.

Treatment

  • Oropharyngeal candidiasis: topical therapy in selected mild cases or oral fluconazole.
  • Oesophageal candidiasis: systemic antifungal therapy, usually fluconazole.
  • ART is important for immune restoration.

3. Herpes Simplex Virus (HSV) Infection

HSV-1 and HSV-2 cause mucocutaneous infections that may become more frequent, severe or prolonged in patients with advanced HIV.

Clinical Appearance

Herpes simplex infection with grouped vesicles
Herpes simplex infection – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Painful grouped vesicles on an erythematous base.
  • Vesicles rupture, producing erosions or ulcers.
  • Oral, perioral, genital or perianal involvement.
  • Advanced immunosuppression may cause large, deep, atypical or slow-healing lesions.

Clinical Significance

AIDS-Defining Manifestations: Chronic HSV ulcers lasting more than one month, or HSV bronchitis, pneumonitis or oesophagitis with onset after the neonatal period.

Treatment

  • Acyclovir.
  • Valacyclovir.
  • Famciclovir.
  • Intravenous acyclovir for severe or disseminated infection.
  • Resistant HSV may require specialist treatment, such as foscarnet.

4. Varicella-Zoster Virus (VZV) Infection

VZV causes primary varicella (chickenpox) and reactivation disease known as herpes zoster (shingles).

Patients with HIV have an increased risk of herpes zoster, including recurrent and complicated disease.

Clinical Appearance

Herpes zoster with dermatomal vesicular eruption
Herpes zoster – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Painful vesicular eruption.
  • Usually follows a unilateral dermatomal distribution.
  • May be preceded by burning, tingling or neuropathic pain.
  • May involve multiple dermatomes or disseminate in immunocompromised patients.

Complications

  • Postherpetic neuralgia.
  • Herpes zoster ophthalmicus.
  • Secondary bacterial infection.
  • Disseminated cutaneous or visceral infection.

Treatment

  • Oral valacyclovir, famciclovir or acyclovir for uncomplicated localised disease.
  • Intravenous acyclovir for severe or disseminated infection.
  • ART and appropriate vaccination help reduce disease burden.

5. Human Papillomavirus (HPV) Infection

HPV infects squamous epithelial cells and produces cutaneous or anogenital lesions.

In patients with HIV, HPV infection may be persistent, extensive, recurrent or difficult to treat.

Clinical Appearance

Common wart caused by human papillomavirus
Common cutaneous wart – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Common cutaneous warts.
  • Plantar warts.
  • Flat warts.
  • Anogenital warts (condylomata acuminata).
  • Cervical, anal and other HPV-associated intraepithelial lesions.

Important HPV Types

HPV Type Clinical Association
6 and 11 Most anogenital warts; low oncogenic risk
16 and 18 High-risk types associated with cervical, anal and other cancers
1, 2 and 4 Commonly associated with cutaneous warts

Clinical Significance

Persistent infection with high-risk HPV types increases the risk of HPV-associated malignancies.

People living with HIV have increased risks of cervical and anal cancer, among other HPV-related cancers.

Treatment and Prevention

  • Cryotherapy.
  • Site-appropriate topical therapies such as imiquimod.
  • Surgical or ablative treatment when indicated.
  • HPV vaccination according to local recommendations.
  • Appropriate cervical and anal cancer screening.

6. Molluscum Contagiosum

Molluscum contagiosum is caused by a poxvirus, the molluscum contagiosum virus.

It produces characteristic smooth, dome-shaped papules with central umbilication.

Clinical Appearance

Molluscum contagiosum showing centrally umbilicated papules
Molluscum contagiosum – clinical image.
Browse source images on Wikimedia Commons

Clinical Features

  • Small, smooth, pearly or skin-coloured papules.
  • Characteristic central depression or umbilication.
  • Usually painless.
  • May involve the face, trunk, extremities or genital region.

Features in Advanced HIV

  • Numerous lesions.
  • Giant or confluent lesions.
  • Extensive facial involvement.
  • Atypical appearance.
  • Persistent or recurrent infection.

Treatment

Effective ART and immune restoration are central to managing extensive HIV-associated molluscum contagiosum.

Selected lesions may be treated with curettage or cryotherapy, although treatment should be individualised because destructive procedures may cause scarring.

7. Comparison of Dermatological Complications

Condition Cause Characteristic Appearance
Seborrhoeic dermatitis Inflammatory disorder associated with Malassezia Greasy yellowish scales on erythematous skin
Candidiasis Candida species White oral plaques or erythematous mucosa
HSV HSV-1 or HSV-2 Painful grouped vesicles or ulcers
Herpes zoster VZV reactivation Painful dermatomal vesicular eruption
HPV Human papillomavirus Verrucous papules or anogenital warts
Molluscum contagiosum Poxvirus Pearly, centrally umbilicated papules

8. HIV Immunosuppression and Skin Disease

Progressive CD4+ T-cell depletion impairs cell-mediated immunity and increases susceptibility to certain dermatological infections.

Flowchart: Development of Dermatological Complications

HIV Infection CD4+ T-Cell Depletion Progressive immunosuppression Impaired Cell-Mediated Immunity Increased Susceptibility to Skin and Mucosal Infections Extensive, Recurrent or Persistent Lesions ART and Immune Restoration

Effective ART often reduces the frequency and severity of dermatological complications by improving immune function.

Important Clarification: Not all dermatological complications are restricted to advanced HIV. Seborrhoeic dermatitis and herpes zoster may occur at relatively preserved CD4 counts.

9. Other Dermatological Manifestations of HIV

  • Kaposi sarcoma: HHV-8-associated vascular tumour producing violaceous patches, plaques or nodules.
  • Bacillary angiomatosis: Bartonella-associated vascular lesions.
  • Oral hairy leukoplakia: Epstein–Barr virus-associated corrugated white plaques, typically on the lateral tongue.
  • Eosinophilic folliculitis: Pruritic follicular papules, particularly in advanced HIV.
  • Pruritic papular eruption: Intensely itchy papules, often affecting the extremities.
  • Dermatophyte infections: May become extensive, atypical or resistant to treatment.
  • Drug eruptions: May occur with antiretrovirals, antibiotics and other medications.

10. High-Yield Examination Summary

Seborrhoeic Dermatitis

  • Greasy scales on scalp and face.
  • Associated with Malassezia.

Candidiasis

  • Oral white plaques.
  • Oesophageal candidiasis is AIDS-defining.

Herpes Simplex Virus

  • Painful grouped vesicles or ulcers.
  • Chronic ulcers lasting more than one month are AIDS-defining.

Varicella-Zoster Virus

  • Painful dermatomal vesicular rash.
  • May become disseminated in advanced immunosuppression.

Human Papillomavirus

  • Persistent or extensive warts.
  • High-risk types increase the risk of HPV-associated cancers.

Molluscum Contagiosum

  • Pearly, centrally umbilicated papules.
  • Extensive or giant lesions suggest significant immunosuppression.
Most Important Examination Point

Dermatological manifestations are very common in HIV infection. Important examples include seborrhoeic dermatitis, candidiasis, HSV, VZV, HPV and molluscum contagiosum.

With increasing immunosuppression, infections may become unusually severe, extensive, persistent or recurrent. Effective ART is central to prevention and management.

Medicine – HIV Infection Revision Notes

Image description
0 Comments